{"id":358,"date":"2012-05-17T08:36:16","date_gmt":"2012-05-17T08:36:16","guid":{"rendered":"https:\/\/asfema.org\/blog\/?p=358"},"modified":"2017-05-14T09:32:29","modified_gmt":"2017-05-14T09:32:29","slug":"costes-socioeconomicos-de-las-enfermedades-raras","status":"publish","type":"post","link":"https:\/\/asfema.org\/blog\/index.php\/costes-socioeconomicos-de-las-enfermedades-raras\/","title":{"rendered":"Costes Socioecon\u00f3micos de las Enfermedades Raras"},"content":{"rendered":"<p>Aqu\u00ed os dejo un informe que ha elaborado FEDER (Federaci\u00f3n Espa\u00f1ola de Enfermedades Raras) acerca de los <strong>costes socioecon\u00f3micos que suponen los tratamientos de algunas de las enfermedades raras<\/strong>. No se incluyen espec\u00edficamente las metab\u00f3licas, pero s\u00ed que nos sirven como referencia.<\/p>\n<p><a href=\"http:\/\/www.enfermedades-raras.org\/index.php?option=com_content&amp;view=article&amp;id=1514:burqol-rd-primeros-resultados-del-proyecto&amp;catid=1:latest-news\">Los Costes Socioecon\u00f3micos de los pacientes con Enfermedades Raras<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Aqu\u00ed os dejo un informe que ha elaborado FEDER (Federaci\u00f3n Espa\u00f1ola de Enfermedades Raras) acerca de los costes socioecon\u00f3micos que suponen los tratamientos de algunas de las enfermedades raras. No se incluyen espec\u00edficamente las metab\u00f3licas, pero s\u00ed que nos sirven como referencia. Los Costes Socioecon\u00f3micos de los pacientes con Enfermedades Raras.<\/p>\n","protected":false},"author":1,"featured_media":3083,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","footnotes":""},"categories":[5,4],"tags":[53,35,337],"acf":[],"_links":{"self":[{"href":"https:\/\/asfema.org\/blog\/index.php\/wp-json\/wp\/v2\/posts\/358"}],"collection":[{"href":"https:\/\/asfema.org\/blog\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/asfema.org\/blog\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/asfema.org\/blog\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/asfema.org\/blog\/index.php\/wp-json\/wp\/v2\/comments?post=358"}],"version-history":[{"count":1,"href":"https:\/\/asfema.org\/blog\/index.php\/wp-json\/wp\/v2\/posts\/358\/revisions"}],"predecessor-version":[{"id":3126,"href":"https:\/\/asfema.org\/blog\/index.php\/wp-json\/wp\/v2\/posts\/358\/revisions\/3126"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/asfema.org\/blog\/index.php\/wp-json\/wp\/v2\/media\/3083"}],"wp:attachment":[{"href":"https:\/\/asfema.org\/blog\/index.php\/wp-json\/wp\/v2\/media?parent=358"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/asfema.org\/blog\/index.php\/wp-json\/wp\/v2\/categories?post=358"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/asfema.org\/blog\/index.php\/wp-json\/wp\/v2\/tags?post=358"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}